IndraLab

Statements

Ponatinib inhibits JAK1. 1 / 1

| 1

reach

"Ponatinib alone suppressed pStat3 (Y705) as efficiently as the combination of PD173074 and ruxolitinib in the presence of erlotinib or AZD6244, suggesting that ponatinib potently inhibits FGFRs and JA[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

25065853

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Ponatinib inhibits JAK1. 1 / 1

INDRA sources:

Databases

Reading